Ascendis Pharma

ISIN US04351P1012

 | 

WKN A14M6X

 

Overview

Description

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals Denmark

Financials

Key metrics

Market capitalisation, EUR 7,068.66 m
EPS, EUR -7.47
P/B ratio 73.17
P/E ratio -
Dividend yield 0.00%

Income statement (2023)

Revenue, EUR 266.72 m
Net income, EUR -481.45 m
Profit margin -180.51%

What ETF is Ascendis Pharma in?

There are 6 ETFs which contain Ascendis Pharma. All of these ETFs are listed in the table below. The ETF with the largest weighting of Ascendis Pharma is the Harbor Health Care UCITS ETF Accumulating.
ETF Weight Investment focus Holdings TER Fund size (in m EUR) Return 1Y WKN ISIN
Harbor Health Care UCITS ETF Accumulating 9.74%
Equity
World
Health Care
Innovation
41 0.89% 15 +6.48% A2PFPC IE00BJQTJ848
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing 0.01%
Equity
World
Multi-Factor Strategy
3,620 0.50% 62 +24.68% WELT0B IE000FPWSL69
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.86%
Equity
United States
Health Care
Biotech
214 0.35% 32 +19.86% A2JDYM IE00BDZVHG35
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating 0.01%
Equity
World
Multi-Factor Strategy
3,620 0.50% 325 +25.13% WELT0A IE0001UQQ933
iShares Nasdaq US Biotechnology UCITS ETF 0.86%
Equity
United States
Health Care
Biotech
214 0.35% 440 +20.83% A2DWAW IE00BYXG2H39
Fidelity Sustainable Research Enhanced US Equity UCITS ETF Acc 0.05%
Equity
United States
Social/Environmental
201 0.20% 452 +37.64% A2P0ZN IE00BKSBGS44
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.